NEUROPHET (380550)

KOSDAQ · 7,960 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

10,00015,00020,00025,000 H 29,800L 6,200 25.0826.0526.08
Mkt Cap
97.1B
Rev (2025)
2.6B
Op Inc (2025)
-16.5B
Net Inc (2025)
-22.4B
PBR
4.99
52W
6K~29K

NEUROPHET operates in the Publishing sector.

Legal name: NEUROPHET Inc.

In fiscal year 2025, NEUROPHET (380550) reported revenue of 2.6 billion KRW, up 18.0% from 2.2 billion KRW a year earlier.

Operating profit was -16.5 billion KRW and net income was -22.4 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 97.1 billion KRW, with a P/B of 4.99.

These figures can be verified in the DART filing (receipt no. 20260320001389).

Financials

YearRevOp IncNet Inc
20252.6B-16.5B-22.4B
20242.2B-14.6B-15.1B

Full financials →

Checks

3 applicable out of 8 items

Check details →

Recent Filings

Semi-Annual Report (2026.06)

Stock Option Grant Report

All filings →

Checks

3 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: 1 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: Convertible bonds outstanding with 0.05% potential dilution.
Capital Increase: 1 capital-increase filing(s) in the last 180 days. [source]

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: No market actions recorded in the last 180 days.

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Recent Filings

DateFiling
2026-08-14Semi-Annual Report (2026.06)
2026-08-04Stock Option Grant Report